⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

GT Biopharma Inc. Common Stock

$8.68
+2.79 (+47.36%)

Volume:

465.518K ($3.95M)

Market Capitalization:

$15.66M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

GT Biopharma Market Segments

Overnight

*No Trades in Segment

After Hours

+0.07(+0.81%)
Open$8.61
Close$8.68
Low$8.35
Low Change-0.26 (-3.00%)
High$8.70
High Change+0.09 (+1.05%)
Range$0.35
Volume19.392K
Dollar Volume$168.32K

Regular Trading Hours

+1.91(+28.98%)
Open$6.59
Close$8.50
Low$6.59
Low Change0.00 (0.00%)
High$8.82
High Change+2.23 (+33.84%)
Range$2.23
Volume442.676K
Dollar Volume$3.76M

Premarket

+0.07(+1.09%)
Open$6.43
Close$6.50
Low$6.18
Low Change-0.25 (-3.89%)
High$6.60
High Change+0.17 (+2.64%)
Range$0.42
Volume3.45K
Dollar Volume$22.43K

After Hours Yesterday

-0.12(-1.94%)
Open$6.18
Close$6.06
Low$6.05
Low Change-0.13 (-2.08%)
High$6.18
High Change+0.00 (+0.00%)
Range$0.13
Volume6.321K
Dollar Volume$38.31K

Regular Trading Hours Yesterday

-0.24(-3.91%)
Open$6.13
Close$5.89
Low$5.50
Low Change-0.63 (-10.28%)
High$6.74
High Change+0.61 (+9.95%)
Range$1.24
Volume146.653K
Dollar Volume$863.82K

Premarket Yesterday

-0.14(-2.22%)
Open$6.21
Close$6.07
Low$5.71
Low Change-0.50 (-8.08%)
High$6.21
High Change+0.00 (+0.00%)
Range$0.50
Volume2.969K
Dollar Volume$18.02K

GT Biopharma News

There is no current news for this stock at the moment.

GT Biopharma Top Trades

GT Biopharma's top trade so far today returned +42.72%, while the top short trade returned -5.31%.

GT Biopharma Moving Averages

5 Day Moving Average (SMA5)$3.51
10 Day Moving Average (SMA10)$1.90
20 Day Moving Average (SMA20)$1.10
50 Day Moving Average (SMA50)$0.66
100 Day Moving Average (SMA100)$0.53
200 Day Moving Average (SMA200)$0.55

GT Biopharma Statistics

Average Volume (30 Days)447.33K
P/E Ratio (Current)-.33
EPS (Current)-$18.16
Dividend Yield2.12%
Free Cash Flow-$14.43M
Cash Ratio2.24
Current Ratio2.61
Quick Ratio2.61
Debt to Equity0.00
Enterprise Value$5.83M
EV to EBITDA-0.36
EV to Sales
Price to Book3.02
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-5.66%
Return on Equity-9.18%

GT Biopharma Stock Splits

There have been 3 stock splits for GT Biopharma (GTBP). The last reverse stock split occured on September 8, 2026 and reduced the outstanding shares at a ratio of 25:1.

DateTypeRatio
Sep 8, 2026Reverse25:1
Feb 5, 2024Reverse30:1
Feb 11, 2021Reverse17:1

GT Biopharma Dividends

There have been no dividends for GT Biopharma (GTBP).